TY  - GEN
AU  - Sinha, Smeeta
AU  - Gould, Lisa J
AU  - Nigwekar, Sagar U
AU  - Serena, Thomas E
AU  - Brandenburg, Vincent
AU  - Moe, Sharon M
AU  - Aronoff, George
AU  - Chatoth, Dinesh K
AU  - Hymes, Jeffrey L
AU  - Miller, Stephan
AU  - Padgett, Claire
AU  - Carroll, Kevin J
AU  - Perello, Joan
AU  - Gold, Alex
AU  - Chertow, Glenn M
PY  - 2022
DO  - 10.1093/ckj/sfab117
SN  - 2048-8505
UR  - https://hdl.handle.net/20.500.12105/23537
AB  - Background: Calcific uraemic arteriolopathy (CUA; calciphylaxis) is a rare disease seen predominantly in patients receiving dialysis. Calciphylaxis is characterized by poorly healing or non-healing wounds, and is associated with mortality, substantial...
LA  - eng
PB  - Oxford University Press
KW  - calciphylaxis
KW  - controlled clinical trial
KW  - design
KW  - SNF472
KW  - rationale
TI  - The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis
TY  - research article
ER  -